
Kypralin TZ 4000mg/500mg Injection
Marketer
Kyna Pharmaceuticals
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Kypralin TZ 4000mg/500mg Injection
Combiflox TZ 4000mg/500mg injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, the dosage and frequency are determined by your physician based on illness severity. Strict adherence to prescribed usage is crucial. Potential side effects include nausea, vomiting, diarrhea, rash, and injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate medical consultation. Prior to use, disclose any antibiotic allergies, kidney, or liver issues; your doctor may adjust the dosage or medication. Generally safe during pregnancy and breastfeeding under medical guidance.
Uses of Kypralin TZ 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Kypralin TZ 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Kypralin TZ 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Kypralin TZ 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.
How Kypralin TZ 4000mg/500mg Injection works:
Kypralin TZ 4000mg/500mg Injection combines piperacillin, a powerful antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial survival. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Kypralin TZ 4000mg/500mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Kypralin TZ, containing 4000mg/500mg, is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Kypralin TZ (4000mg/500mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Kypralin TZ 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
The injectable formulation of Kypralin TZ (4000mg/500mg) requires careful administration in individuals with impaired renal function. Dosage modification for Kypralin TZ (4000mg/500mg) injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Kypralin TZ 4000mg/500mg Injection in patients with liver disease appears to pose minimal risk. Available evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Kypralin TZ 4000mg/500mg Injection :
Omitting a scheduled dose of Kypralin TZ 4000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Kypralin TZ 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
